Navigation Links
Building bridges between the clinic and the laboratory
Date:8/4/2008

Cambridge, UK, 04 August 2008 - Disease Models & Mechanisms (DMM) is the first journal to focus on translational research and the use of model organisms to advance human health. Published by the Company of Biologists, DMM is a highly anticipated biomedical research journal which officially launched its inaugural issue both in print and online today at http://DMM.biologists.org.

DMM focuses on human disease and the research necessary to develop treatments for illness. The field of translational medicine where basic science research is "translated" into treatments and cures for disease has been growing exponentially, particularly given the recent advances in genomics and life sciences, and shifts in global research funding. DMM aims to fill a niche in translational research by publishing articles about human disease and the model organisms used in biomedical research.

The special inaugural issue features editorial commentary, review articles, and research highlights on topics ranging from cancer detection, to understanding human diseases using flies or worms and the future impact of mouse genetics on humankind. Future issues will include primary research articles, and DMM continues to invite authors to submit articles which focus on human disease. Interviews and Podcasts focusing on areas of special interest will become regular features.

DMM's founders believe that the journal will provide a community forum for clinicians and scientists to discuss their findings and observations. DMM's Editor-in-Chief, Vivian Siegel, invites students, fellows, policymakers, clinicians, and scientists to "use the journal and its website to share resources and discoveries".

In addition to its publishing goals, the journal is committed to assisting early-career scientists by offering travelling fellowships to graduate students and postdoctoral fellows. Awards of up to US$5000/₤2500 are offered to facilitate collaborative visits to other laboratories worldwide. Fellowship application forms can be downloaded from the DMM website.

Disease Models & Mechanisms will publish 5 issues in 2008. Issue 1 is a special inaugural issue; issues 2/3 and 4/5 will be combined double issues. From 2009, DMM will be published every month (12 issues/year). Authors benefit from a free trial period for access to DMM, which will be available until at least spring 2009. DMM is a new addition to the international journals published by the Company of Biologists, a not-for-profit publisher based in Cambridge, UK.


'/>"/>

Contact: Donna Perry
donna@biologists.com
44-122-342-6164
The Company of Biologists
Source:Eurekalert

Related biology news :

1. 1/3 of reef-building corals face extinction
2. NJIT architect professor advocates best-building practices for high wind regions
3. Manchester clears first hurdle in €170 million biobank building boom
4. Building on pyramids of trash
5. UCI awarded $27.2 million for new stem cell building
6. Scientists make chemical cousin of DNA for use as new nanotechnology building block
7. In Todays Economy, You Can Strengthen Your Company by Building Your Brand
8. International workshop to address capacity building for rainforest leaders
9. Building the future -- 21st century nano tools to repair the nervous system
10. Building disease-beating wheat
11. Building blocks of life formed on Mars
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2016)... Nov. 23, 2016 Cercacor today introduced Ember ... their trainers non-invasively measure hemoglobin, Oxygen Content, ... and Respiration Rate in approximately 30 seconds. Smaller than ... and immediate access to key data about their bodies ... training regimen. Hemoglobin carries oxygen to ...
(Date:11/21/2016)... VILNIUS, Lithuania , Nov. 21, 2016 /PRNewswire/ ... identification and object recognition technologies, today announced that ... for smart cards was submitted for the ... and successfully passed all the mandatory steps of ... III evaluation is a continuing test of fingerprint ...
(Date:11/17/2016)... 17, 2016  AIC announces that it has just released a new white paper ... high-performance scale-out plus high speed data transfer storage solutions. Photo - ... ... ... Setting up a high performance computing or HPC ...
Breaking Biology News(10 mins):
(Date:11/30/2016)... , Nov. 30, 2016 /PRNewswire/ - Portage Biotech Inc. ... Exchange: PBT.U), is excited to announce the formation ... on developing preclinical ophthalmology assets through proof of ... anti-inflammatory created by Portage Pharmaceuticals Limited and being ... ocular surface and anterior segment diseases. This agent ...
(Date:11/30/2016)...  Tempus, a technology company focused on supporting ... Cancer Center have partnered to better determine which ... treatment based on next generation genomic and transcriptomic ... research collaboration, Tempus will provide sequencing and analysis ... to Penn. Utilizing next-generation sequencing, machine learning and ...
(Date:11/30/2016)... --  Merck , a leading science and technology company, ... of agreements with Evotec AG, whereby Evotec AG will ... such as CRISPR and shRNA libraries. Combining access to ... pathway to explore and identify new drug targets. ... targets, a process that can be time- and labor-intensive," ...
(Date:11/30/2016)... Park, North Carolina (PRWEB) , ... November 30, 2016 , ... ... approved the names and symbols for four elements: nihonium (Nh), moscovium (Mc), tennessine ... a 5-month period of public review, the names earlier proposed by the discoverers have ...
Breaking Biology Technology: